# Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

> clinical trial · VERIFIED · 2026-07-09

Status: COMPLETED · Sponsor: Chongqing Precision Biotech Co., Ltd · Condition: Colorectal Cancer

- Company: Chongqing Precision Biotech Co., Ltd
- Sector: Colorectal Cancer
- Primary source: https://clinicaltrials.gov/study/NCT05415475

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.